Anzeige
Mehr »
Sonntag, 14.06.2026 - Börsentäglich über 12.000 News

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A0B7QK | ISIN: GB0034330679 | Ticker-Symbol: DWV
Hamburg
12.06.26 | 08:10
0,021 Euro
-2,38 % -0,001
Branche
Dienstleistungen
Aktienmarkt
Sonstige
1-Jahres-Chart
CELLBXHEALTH PLC Chart 1 Jahr
5-Tage-Chart
CELLBXHEALTH PLC 5-Tage-Chart
RealtimeGeldBriefZeit
0,0200,02213.06.

Aktuelle News zur CELLBXHEALTH Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
29.05.CelLBxHealth enters service agreement with AstraZeneca, shares pop1
29.05.WINNERS & LOSERS: CelLBxHealth jumps on AstraZeneca partnership3
29.05.CelLBxHealth shares jump on partnership with AstraZeneca5
29.05.CelLBxHealth PLC - MSA with Global Pharmaceutical Company-
CELLBXHEALTH Aktie jetzt für 0€ handeln
18.05.CelLBxHealth PLC - Collaboration with AdventHealth for two studies-
11.05.CelLBxHealth shares jump on forecast for 50% revenue growth in 20261
11.05.WINNERS & LOSERS: Asos sells Lichfield centre; CelLBxHealth revenue up4
11.05.CelLBxHealth PLC - Q1 trading update and outlook for 2026-
30.04.CelLBxHealth PLC - Confirmation of Q1 trading update-
20.04.CelLBxHealth PLC - Research Collaboration with The Royal Marsden-
16.04.CelLBxHealth PLC - Board changes - Replacement2
13.02.CelLBxHealth PLC - Aligning Regulatory Approach with Commercial Needs426CelLBxHealth strengthens cost discipline by aligning FDA regulatory approach with current commercial needs GUILDFORD, SURREY / ACCESS Newswire / February 13, 2026 / CelLBxHealth plc (AIM:CLBX), a leader...
► Artikel lesen
13.02.CelLBxHealth PLC - Aligning Regulatory Approach with Commercial Needs-
16.01.IN BRIEF: Cellbxhealth eyes cost savings as revenue falls in 20254
16.01.CelLBxHealth warns of lower-than-expected 2025 revenue2
16.01.CellBxHealth verfehlt Umsatzziele für 2025 und kündigt Sparmaßnahmen an3
16.01.CelLBxHealth PLC Announces Preliminary Fourth Quarter 2025 Financial Results277GUILDFORD, SURREY / ACCESS Newswire / January 16, 2026 / CelLBxHealth plc (AIM:CLBX), a leader in circulating tumour cell (CTC) intelligence, with tests and services supporting research, drug development...
► Artikel lesen
16.01.CelLBxHealth reports £1.4 million in 2025 revenue, implements cost cuts3
16.01.CelLBxHealth PLC - Preliminary Fourth Quarter 2025 Financial Results2
12.01.CelLBxHealth PLC Announces Board Changes369GUILDFORD, SURREY / ACCESS Newswire / January 12, 2026 / CelLBxHealth plc (AIM:CLBX), a leader in circulating tumour cell (CTC) intelligence, with tests and services supporting research, drug development...
► Artikel lesen
Weiter >>
40 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1